Known targets — ChEMBL curated mechanism
ADRA2AADRA2BADRA2CADRB2AGTR1AVPR1AAVPR1BAVPR2BDKRB2CALCRCHRNA3CHRNB4ESR1ESR2GHSRGNRHRGSC1HSPA8MALT1MC1RMC4RNOS1NOS2NOS3OPRK1OXTRRAMP1RAMP2RAMP3SCN5ASSTR1SSTR2SSTR3SSTR4SSTR5dacAdacBdacCfolPftsImrcAmrcBmrdArplArplBrplCrplDrplErplFrplJrplKrplLrplMrplNrplOrplPrplQrplRrplSrplTrplUrplVrplWrplXrplYrpmArpmBrpmCrpmDrpmErpmFrpmGrpmHrpmIrpmJrpsArpsBrpsCrpsDrpsErpsFrpsGrpsHrpsIrpsJrpsKrpsLrpsMrpsNrpsOrpsPrpsQrpsRrpsSrpsTrpsUykgMykgO
The experimentally established mechanism targets of Acetic Acid. The predicted profile below is derived independently by chemical similarity — agreement is a validation signal, a miss is honest.
Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | FFAR3 | O14843 | 2/20 | 0.58 |
| ▸ | LCK | P06239 | 1/20 | 0.58 |
| ▸ | FYN | P06241 | 1/20 | 0.58 |
| ▸ | GLRA1 | P23415 | 1/20 | 0.47 |
| ▸ | SLC6A9 | P48067 | 1/20 | 0.47 |
| ▸ | OR51E2 | Q9H255 | 1/20 | 0.47 |
| ▸ | LMNA | P02545 | 5/20 | 0.43 |
| ▸ | GABRR1 | P24046 | 3/20 | 0.43 |
| ▸ | BLM | P54132 | 3/20 | 0.43 |
| ▸ | PAOX | Q6QHF9 | 3/20 | 0.43 |
| ▸ | ALOX15 | P16050 | 2/20 | 0.43 |
| ▸ | PMP22 | Q01453 | 1/20 | 0.43 |
| ▸ | THRB | P10828 | 2/20 | 0.42 |
| ▸ | KMT2A | Q03164 | 2/20 | 0.42 |
| ▸ | NPSR1 | Q6W5P4 | 2/20 | 0.42 |
| ▸ | GABRR3 | A8MPY1 | 1/20 | 0.42 |
| ▸ | GABRP | O00591 | 1/20 | 0.42 |
| ▸ | GABRD | O14764 | 1/20 | 0.42 |
| ▸ | HDAC3 | O15379 | 1/20 | 0.42 |
| ▸ | GABBR2 | O75899 | 1/20 | 0.42 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| Acetic Acid SCHEMBL1665368 | 1.00 | FFAR3 (0.58) | FFAR3LCKFYNGLRA1SLC6A9 | |
| Acetic Acid SCHEMBL20617 | 1.00 | FFAR3 (0.58) | FFAR3LCKFYNGLRA1SLC6A9 | |
| Acetic Acid SCHEMBL11012463 | 1.00 | FFAR3 (0.58) | FFAR3LCKFYNGLRA1SLC6A9 | |
| Acetic Acid SCHEMBL344632 | 1.00 | — | — | |
| Acetic Acid SCHEMBL9098767 | 1.00 | FFAR3 (0.58) | FFAR3LCKFYNGLRA1SLC6A9 | |
| Acetic Acid SCHEMBL8527135 | 1.00 | FFAR3 (0.58) | FFAR3LCKFYNGLRA1SLC6A9 | |
| Acetic Acid SCHEMBL1058300 | 1.00 | FFAR3 (0.58) | FFAR3LCKFYNGLRA1SLC6A9 | |
| Acetic Acid SCHEMBL3420431 | 1.00 | FFAR3 (0.58) | FFAR3LCKFYNGLRA1SLC6A9 | |
| Acetic Acid SCHEMBL220259 | 1.00 | FFAR3 (0.58) | FFAR3LCKFYNGLRA1SLC6A9 | |
| Acetic Acid SCHEMBL6251803 | 1.00 | FFAR3 (0.58) | FFAR3LCKFYNGLRA1SLC6A9 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 57 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| CN-114717224-A | Method for enriching and identifying glycosylated ribonucleic acid (glycoRNA) based on solid phase | 苏州大学 | 2022-07-08 | — | — | CN | claimed |
| US-11970738-B2 | Compositions, devices, systems, and methods for using a nanopore | THE REGENTS OF THE UNIVERSITY OF CALIFORNIA (US) | 2024-04-30 | — | — | US | disclosed |
| EP-3798317-B1 | COMPOSITIONS, DEVICES, SYSTEMS, AND METHODS FOR USING A NANOPORE | UNIV CALIFORNIA (US) | 2024-01-03 | — | — | EP | disclosed |
| CN-114717224-A | Method for enriching and identifying glycosylated ribonucleic acid (glycoRNA) based on solid phase | 苏州大学 | 2022-07-08 | — | — | CN | disclosed |
| US-20210189482-A1 | Compositions, Devices, Systems, and Methods for Using a Nanopore | THE REGENTS OF THE UNIVERSITY OF CALIFORNIA | 2021-06-24 | — | — | US | disclosed |
| EP-3798317-A1 | COMPOSITIONS, DEVICES, SYSTEMS, AND METHODS FOR USING A NANOPORE | The Regents of the University of California (US) | 2021-03-31 | — | — | EP | disclosed |
| US-20200325535-A1 | Compositions, Devices, Systems, and Methods for Using a Nanopore | THE REGENTS OF THE UNIVERSITY OF CALIFORNIA | 2020-10-15 | — | — | US | disclosed |
| US-10344327-B2 | Compositions, devices, systems, and methods for using a nanopore | THE REGENTS OF THE UNIVERSITY OF CALIFORNIA (US) | 2019-07-09 | — | — | US | disclosed |
| US-10208342-B2 | Compositions, devices, systems, and methods for using a nanopore | THE REGENTS OF THE UNIVERSITY OF CALIFORNIA (US) | 2019-02-19 | — | — | US | disclosed |
| US-10202645-B2 | Compositions, devices, systems, and methods for using a nanopore | THE REGENTS OF THE UNIVERSITY OF CALIFORNIA (US) | 2019-02-12 | — | — | US | disclosed |
| US-6426186-B1 | POLYNUCLEOTIDES | INCYTE GENOMICS, INC | 2002-07-30 | — | — | US | disclosed |
| EP-1183351-A1 | PHOSPHOLIPID TRANSFER PROTEIN | Incyte Genomics, Inc. (US) | 2002-03-06 | — | — | EP | disclosed |
| EP-1181364-A1 | LIPID METABOLISM TRANSCRIPTION FACTOR | Incyte Genomics, Inc. (US) | 2002-02-27 | — | — | EP | disclosed |
| US-20020015950-A1 | ATHEROSCLEROSIS-ASSOCIATED GENES | INCYTE PHARMACEUTICALS, INC. | 2002-02-07 | — | — | US | disclosed |
| US-6287786-B1 | NUCLEIC ACID MOLECULES ENCODING A NEW MAMMALIAN PROTEIN AND TO THE USE OF THESE MOLECULES IN THE CHARACTERIZATION, DIAGNOSIS, AND TREATMENT OF CONDITIONS SUCH AS DISORDERS ASSOCIATED WITH CELL PROLIFERATION, LIPID METABOLISM AND TRANSPORT. | INCYTE GENOMICS, INC. | 2001-09-11 | — | — | US | disclosed |
| US-6245526-B1 | MAMMALIAN NUCLEOTIDE SEQUENCES WHICH CODE POLYPEPTIDES FOR THE CLASSIFICATION, DIAGNOSIS, TREATMENT, AND PREVENTION OF CELL PROLIFERATIVE AND LIPID DEFECTS | INCYTE PHARMACEUTICALS, INC. | 2001-06-12 | — | — | US | disclosed |
| US-6242185-B1 | NUCLEOTIDE SEQUENCES CODING A REGULATORY POLYPEPTIDE FOR THE CLASSIFICATION, DIAGNOSIS, PREVENTION, AND TREATMENT OF CELL PROLIFERATIVE DEFECTS | INCYTE GENOMICS, INC. | 2001-06-05 | — | — | US | disclosed |
| US-6168933-B1 | NUCLEOTIDE SEQUENCES CODING A TRANSPORT PROTEIN; FOR THE CLASSIFICATION, DIAGNOSIS, PREVENTION, AND TREATMENT OF DEFECTS IN CELL PROLIFERATION, LIPID METABOLISM AND TRANSPORT | INCYTE PHARMACEUTICALS, INC. | 2001-01-02 | — | — | US | disclosed |
| WO-2000075318-A1 | PHOSPHOLIPID TRANSFER PROTEIN | INCYTE GENOMICS, INC. (US) | 2000-12-14 | — | — | WO | disclosed |
| WO-2000073443-A1 | LIPID METABOLISM TRANSCRIPTION FACTOR | INCYTE GENOMICS, INC. (US) | 2000-12-07 | — | — | WO | disclosed |